Home›Research›Compare›NAD+ vs SS-31
Peptide ComparisonNAD+ vs SS-31
Both are Longevity & Cellular peptides.
NAD+
NAD
Half-life: ~1–2 hours (IV); variable (oral)
447 providers listed
SS-31
Elamipretide
Half-life: ~2-3 hours
50 providers listed
NAD+ is carried by more providers on PeptideBase (447 vs 50); otherwise the two are closely matched on the measures we track.
NAD+
Evidence
Half-life
~1–2 hours (IV); variable (oral)
SS-31
Evidence
Half-life
~2-3 hours
| Your goal | Better option |
|---|---|
| Further along in FDA review | SS-31 |
| Oral administration option | NAD+ |
| Lower typical price per mg | NAD+ |
| More provider options (447 vs 50) | NAD+ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
NAD+
SS-31
NAD+
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and…
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Extracellular Lactate Reprograms Mitochondrial Metabolism and NAD(+)/NADH Redox Balance in Blood-Brain Barrie…
+4 more
SS-31
Protective Effect of Mitochondria-Targeted Polydopamine Nanoparticles in Alleviating Hepatic Ischemia-Reperfu…
Effect of mitochondrial dysfunction on scar formation after spinal cord injury.
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after…
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF…
+7 more
About NAD+
NAD+ is a coenzyme central to cellular energy metabolism, serving as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It is also a required substrate for sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, gene expression, and mitochondrial biogenesis. NAD+ levels decline measurably with age; IV or subcutaneous delivery aims to restore intracellular pools more directly than oral precursors such as NMN or NR.
About SS-31
Targets cardiolipin in inner mitochondrial membrane; stabilizes cristae structure; enhances electron transport chain efficiency; reduces mitochondrial ROS
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
NAD+
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
SS-31
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
NAD+
SS-31
Where to source these peptides
NAD+
447 listed
Browse directory →
Providers offeringSS-31
50 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). NAD+ vs SS-31 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/nad-plus/ss-31